2m 2m 2m 2m 2m 2m 2m
MediciNova (MNOV)
NASDAQ
$1.79+$0.16 (+9.51%)
Price as of Oct 02, 2026 5:08 PM EDT- $80.2MMarket Cap
- 31.45%1-Year Change
- BiotechnologyIndustry
MediciNova (MNOV)
$1.79+$0.16 (+9.51%)
MNOV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.63 | ||
Change | -$0.05 (-2.69%) | ||
Open | $1.69 | ||
High | $1.72 | ||
Low | $1.63 | ||
Previous Close | $1.68 | ||
Volume | 263,256 | ||
30-Day Average Volume | 839,113 | ||
1-Week Change | -38.49% | ||
1-Month Change | 13.19% | ||
1-Year Change | 31.45% | ||
3-Year Change | -22.01% | ||
5-Year Change | -57.66% | ||
Fundamentals | |||
Shares Outstanding | 49.2M | ||
Total Assets | $40.4M | ||
Market Cap | $80.2M | ||
Enterprise Value | $54.8M | ||
Period: QTR TTM FY | |||
Revenue | $458,439.00 | ||
Net Income | -$2.3M | ||
Free Cash Flow | -$1.9M | ||
EBIT | -$2.3M | ||
EBITDA | -$2.3M | ||
Net Working Capital | $23.0M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 120 | ||
P/B | 2 | ||
P/E | -33 | ||
PEG | N/A | ||
Price/Free Cash Flow | -42 | ||
Price/Operating Cash Flow | -42 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue